MADISON, N.J., June 27 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) has
announced that Bernard Poussot, 56, Wyeth's President and Chief Executive
Officer, has assumed the additional position of Chairman of the Board,
effective today.
The announcement is pursuant to a previously announced election by the
Company's Board of Directors, and is the culmination of a succession plan
that began in April 2006 when Mr. Poussot was promoted to President and
Vice Chairman. In January 2007, he was named President and Chief Operating
Officer and was elected to the Company's Board of Directors. He became CEO
on January 1, 2008.
The Company announced in April that Robert Essner, 60, had decided to
retire from the Company effective June 27, 2008. Mr. Essner held the
position of Chairman since January 2003 and served as Wyeth's Chief
Executive Officer from 2001 to 2007.
Wyeth is one of the world's largest research-driven pharmaceutical and
health care products companies. It is a leader in the discovery,
development, manufacturing and marketing of pharmaceuticals, vaccines,
biotechnology products, nutritionals and non-prescription medicines that
improve the quality of life for people worldwide. The Company's major
divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort
Dodge Animal Health.
SOURCE Wyeth
 back to top
Related links:
http://www.wyeth.com
CONTACT:
Media, Douglas Petkus, +1-973-660-5218, or
Investors, Justin Victoria, +1-973-660-5340, both of Wyeth
|
